An Executive Council/NYVCA Event

Top Investment Opportunities

from NY’s Digital Health & Biotechnology Community

June 13th | New York City

11:00am - 4:30pm | Rise | 43 West 23rd Street


Data & AI| Mobile | Diagnostics | Therapeutics| SaaS | Wearables

200+ Attendees

  • CEO/Founders
  • VC, PE, Strategic Investors
  • Senior execs from corporate side


NYC is home to cutting edge startups, massive investment dollars and a diverse ecosystem, including universities and academic medical centers.

Past 12 Months

250 inventions * $1Bn Dollars Invested Across 63 Deals * 300 License Agreements * $1.1Bn in IP Revenues


11:00 am

Registration, Coffee & Networking

Read more
12:00 pm


Karen Ignagni, CEO, EmblemHealth

Read more
12:20 pm

Fireside Chat

Donato Tramuto, CEO, Tivity Health

Lindsay Jurist-Rosner, CEO, Wellthy (moderator)

What will the CEO of the future look like? Leadership is not just about meeting financial expectations, it's also about leading a company with compassion and purpose – wise business leaders understand that a strong culture of employee acceptance is essential to a productive, fruitful and resilient business.

Read more
12:40 pm

Roundtable: Beyond On-Demand

The Massive Play Across Content, B2C and Cracking the B2B Landscape

Katherine Ryder, CEO, Maven

Chaim Indig, CEO, Phreesia

Jay Parkinson, Founder, Sherpaa

Samer Hamadeh, CEO, Zeel

Derek Flanzraich, CEO, Greatist

Scott Styles, Managing Director, FTI Consulting (Moderator)

Health represents the second fastest growing on-demand segment. And, consumers aren't the only ones getting in on the action.

Read more
1:20 pm

Roundtable: The View from Big Pharma

Technology Innovations & How to Partner

Sree Kant, Head of External Partnering, Pfizer

Bob Silverman, PHC Business Strategy & Partnering, Diagnostics, Roche

Clark Golestani, Former President, Emerging Businesses and Global CIO (retired) Merck

Randy Sunberg, Partner, Morgan Lewis (Moderator)

Among other topics, this session will cover:

  • Working with an informed consumer
  • The ‘retail mindset’ transforming healthcare
Read more
2:00 pm

Roundtable: The Investment Scene – What it Takes to Raise Money in this Environment

Raising Money, Valuations & Identifying Winners – The Investors' Perspective

Gregg Michaelson, Partner, Edison Ventures

Adam Dakin, Partner, DreamIt Ventures

Michael Greeley, Partner, Flare Capital 

Stacey Seltzer, Partner, Aisling Capital

Evan Smith, Managing Director, FTI Consulting (Moderator)

Read more
2:40 pm

Networking Break

Read more
3:00 pm

Fireside Chat

Eric Marcotulli, CEO, Elysium Health

Robert Johnston, CEO, Executive Council / NYVCA (Moderator)

Building a company from the ground up is hugely difficult (as every founder knows). And, truly disruptive models simply can't exist in the traditional healthcare constructs. In the "Wellness" category, there are dozens and dozens of companies pursuing prevention and proactivity. 

Read more
3:20 pm

Roundtable – Life Sciences

The public and private investment required to build a proper Life Sciences ecosystem in NYC

Michael Aberman, CEO, Quentis

Ed Rosen, CEO, Elucida Oncology

Sonia Gulati, Asst. Director, New York Ventures, Empire State Development Corporation

Doug Thiede, SVP Life Sciences & Healthcare, New York City Economic Development Corporation

Andre Moura, Managing Director, New Mountain Capital

Mark Sodano, Managing Partner, Tri-State Life Sciences Practice Leader, Deloitte (Moderator)

Read more
4:00 pm

Roundtable: Here it Comes – The AI & Machine Learning Juggernaut has Just Begun

What You Need to Know Now in Data, AI & Machine Learning

Sundeep Bhan, CEO, Prognos

Dr. Thomas Fuchs, CEO, PAIGE.ai

Adam Hanina, CEO, AiCure

Fred Nazem, CEO, Rejuvenan

Alex Bisignano CEO, Phosphorus

Peter Micca, Managing Partner, National Healthtech Practice Leader, Deloitte (Moderator)

All facets of healthcare are being massively disrupted by AI and machine learning. The patient journey at home, in the waiting room, at the point of care and even billing and follow up are all areas that are feeling the innovative weight of AI and machine learning. 

Read more
4:30 pm


Read more


HBTS is a great opportunity to showcase all of the best technology coming out of New York City. I look forward to the next event.

Tom Cirrito
General Partner Founder & CEO, Filament

VentriNova has benefited a great deal from our association with the Summit. Our presentation put us in front of New York’s biotech community so that we could tell our unique story of being the only company in the world that has demonstrated the ability to make de novo heart muscle cells in diseased heart tissue with a significant improvement in heart function. And, we met and recruited our CEO from [HBTS's] Executive-in-Residence Program!

Dr. Hina Chaudhry
Founder, VentriNova

The Summit provides the ideal venue to discuss and refine our strategy by interacting with seasoned entrepreneurs and subject-matter experts. Beyond the main event, the support from the ETS/Tech Connect team translated into numerous connections to potential investors and had a direct impact on our fundraising process. Currently no other biotech-related program in NYC can provide that value and breadth of support to life sciences entrepreneurs.

Frederico Lourenco
Co-Founder at Repairogen

Want to speak at our future events?

If you’d like to speak at one of future events, please get in touch.

Subscribe to our newsletter to stay informed:

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.


Potential Sponsor? Speaker? Questions? Get in touch.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

HBTS 2018